Support Cells Gain Stem Cell-Like Properties After Nerve Injury

When peripheral nerves are severed, Schwann cells at the injury site begin to proliferate and exhibit stem cell-like gene expression patterns.

Dec 1, 2017
Diana Kwon

REGENERATION: Fluorescently labeled Schwann cells (pink) migrate into the wound site of a severed nerve and lay the foundations for nerve repair.MELANIE CLEMENTS, PARRINELLO LAB


The paper
M.P. Clements et al., “The wound microenvironment reprograms Schwann cells to invasive mesenchymal-like cells to drive peripheral nerve regeneration,” Neuron, 96:98-114.e7, 2017.

To protect and repair
In the peripheral nervous system, axons are able to mend themselves after injury thanks to Schwann cells, a type of glial cell responsible for producing myelin, the fatty substance that wraps around some nerve fibers. Schwann cells migrate to the injury site and help guide the regrowing axons through a connective-tissue bridge that forms across the gap.

Dual identities
Prior studies have shown that while aiding repair, Schwann cells transition from a myelinating phenotype to a progenitor-like state. This switching is similar to what happens when adult cells are genetically reprogrammed into induced pluripotent stem cells for use in regenerative medicine, says Simona Parrinello, a cell biologist at Imperial College London. “But instead of being forced experimentally, it happens naturally.”

Molecular markers
To identify the molecular changes that accompany this transition, Parrinello and her colleagues isolated Schwann cells from both severed and intact mouse nerves and characterized their transcriptomes. The analysis revealed that Schwann cells in the injured area were more proliferative and invasive, and displayed gene expression patterns that were more stem cell–like than those from unaffected parts of the nerve.

Cancer connections
“Schwann cell tumors usually arise from injury sites, and this is probably why,” says Haesun Kim, a biologist at Rutgers University who was not involved in the work. These findings could also have implications for regenerative medicine, Parrinello adds. “If we understand how a cell does this as part of a normal regenerative process, we might be able to understand what we need to do [to make] experimental reprogramming more efficient.”

November 2018

Intelligent Science

Wrapping our heads around human smarts


Sponsored Product Updates

Improved Accuracy in Multiplex Assays

Improved Accuracy in Multiplex Assays

Interference by endogenous antibodies in immunoassays is a well-documented phenomenon. Download this poster to learn about the profound effects that this can have on the data and how development expertise and assay design can eliminate or reduce the effects of endogenous antibodies.

Complete Pathology Solutions: Make Every Minute Count

Complete Pathology Solutions: Make Every Minute Count

From sample collection and handling, to fixation and processing, tissue staining, and covering all your IHC and water purification needs—you can have confidence in the quality of your results with MilliporeSigma's one-stop pathology solution.

Preparing Cell Or Tissue Lysates For ELISA Kits

Preparing Cell Or Tissue Lysates For ELISA Kits

RayBiotech manufactures over 2,000 high fully validated, GMP-compliant ELISA kits. In this blog post we explain how to prepare cell or tissue lysates for ELISA Kits.

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.